Risk Management for Pharmaceutical Project Schedules

摘要

In today's market, the requirement for success for any construction project includes completion on time and within budget, with certain expectations of technical and quality performance. However, some industries are more quality-and schedule-dependent than others. In the biotech, pharmaceutical, life sciences and R&D industries, any delay in the completion and startup of the facility immediately incurs high-dollar revenue losses. The ultimate objective, often achieved at higher built cost, is to minimize the rime-to-market for the manufactured product.